Company Team Search Site Map Careers Privacy Statement
:: Home
:: About Us
:: Research
:: Products
:: Services
:: Facilities
:: Contact us
Virchow Products
Biotech R&D

Our dedicated research facility is recognized by Government of India.

Our R&D center has a Doctoral Program (Ph.D) that is registered with Jawarlal Nehru Techonlogoical University, Osmania University, Nagarjuna University and Andhra University.

VBPL also has ongoing collaborative research projects with internationally reputable CSIR labs like Center for Cellular and Molecular Biology, Indian Institute of Chemical Technology, National Institutes of Nutrition and University of Michigan, USA.

Patient Assistance

At Virchow Biotech, our mission is to serve patients. As a science-based, patient-focused organization, we develop innovative therapies to treat serious illnesses at an affordable cost.  Our cost effective medicines have made a difference in the lives of millions.

Virchow’s patient assistance programs, provide medicines for

qualifying patients who are with limited financial resources. For details, please write us to learn more about available programs.
News & Events

Virchow Biotech is filing for U.S.Food and Drug administration’s (FDA) approval for its in house developed advanced wound care products.

Virchow Biotech received Drug control’s (DCGI) approval for conducting clinical trials on periogen, an indigenously developed recombinant therapeutic product for periodontal diseases

Virchow Biotech and Ranbaxy signed an MOU to market Virchow’s indigenously developed recombinant therapeutic protein for osteoporosis treatment. We are the first in the world to launch this biogeneric product